Startseite Medizin Putting the pieces together: cryptorchidism – do we know everything?
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Putting the pieces together: cryptorchidism – do we know everything?

  • Marta Diana Komarowska , Adam Hermanowicz EMAIL logo und Wojciech Debek
Veröffentlicht/Copyright: 30. Juli 2015

Abstract

Cryptorchidism is one of the most common birth defects in male children, and it has a potential impact on future health. It is the best-characterized risk factor for reduced fertility and testicular cancer. However, the etiology of cryptorchidism remains largely unknown. In the literature, we find different opinions and theories on this topic. Probably, the etiology is multifactorial, and hormonal, genetic and environmental factors may regulate testicular development and descent from intra-abdominal location into the bottom of the scrotum. The descent of the testis is a complex, two-stage process. A critical role in testicular descent has been attributed to androgens, insulin-like hormone 3 (insl3) and anti-Müllerian hormone. It is believed that interaction between Leydig and Sertoli cells may cause impaired spermatogenesis. Based on recent knowledge of germ cell development, it is believed that the best treatment for undescended testis is orchiopexy between 6th and 12th month of life. Long follow-up studies are needed to focus on the effect of this recommendation.


Corresponding author: Adam Hermanowicz, Assoc. Prof. MD, PhD, Department of Pediatric Surgery, Medical University of Bialystok, Poland, E-mail:

References

1. Barthold JS, González R. The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J Urol 2003; 170(6 Pt 1):2396–401.10.1097/01.ju.0000095793.04232.d8Suche in Google Scholar

2. Mathers MJ, Sperling H, Rübben H, Roth S. The undescended testis: diagnosis, treatment and long-term consequences. Dtsch Arztebl Int 2009;106:527–32.Suche in Google Scholar

3. Taran I, Elder JS. Results of orchiopexy for the undescended testis. World J Urol 2006;24:231–9.10.1007/s00345-006-0056-4Suche in Google Scholar

4. Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update 2008;14:49–58.10.1093/humupd/dmm027Suche in Google Scholar

5. Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebaek NE. Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann NY Acad Sci 2001;948:90–9.10.1111/j.1749-6632.2001.tb03990.xSuche in Google Scholar

6. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 2004;363:1264–9.10.1016/S0140-6736(04)15998-9Suche in Google Scholar

7. Preiksa RT, Zilaitiene B, Matulevicius V, Skakkebaek NE, Petersen JH, et al. Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up. Hum Reprod 2005;20:1928–32.10.1093/humrep/deh887Suche in Google Scholar PubMed

8. Acerini CL, Miles HL, Dunger DB, Ong KK, Hughes IA. The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort. Arch Dis Child 2009;94:868–72.10.1136/adc.2008.150219Suche in Google Scholar PubMed

9. Scorer CG. The descent of the testis. Arch Dis Child 1964;39:605–9.10.1136/adc.39.208.605Suche in Google Scholar PubMed PubMed Central

10. Cortes D, Kjellberg EM, Breddam M, Thorup J. The true incidence of cryptorchidism in Denmark. J Urol 2008;179:314–8.10.1016/j.juro.2007.08.158Suche in Google Scholar PubMed

11. Main KM, Skakkebaek NE, Toppari J. Re: The true incidence of cryptorchidism in Denmark: D. Cortes, E. M. Kjellberg, M. Breddam and J. Thorup, J Urol 2008; 179: 314–318. J Urol 2009;181:922–4.10.1016/j.juro.2008.10.048Suche in Google Scholar PubMed

12. Rey RA, Grinspon RP. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab 2011;25:221–38.10.1016/j.beem.2010.08.013Suche in Google Scholar

13. Hutson JM, Clarke MC. Current management of the undescended testicle. Semin Pediatr Surg 2007;16:64–70.10.1053/j.sempedsurg.2006.10.009Suche in Google Scholar

14. Hughes IA, Acerini CL. Factors controlling testis descent. Eur J Endocrinol 2008;159(Suppl 1):S75–82.10.1530/EJE-08-0458Suche in Google Scholar

15. Kubota Y, Temelcos C, Bathgate RA, Smith KJ, Scott D, et al. The role of insulin 3, testosterone, Müllerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 2002;8:900–5.10.1093/molehr/8.10.900Suche in Google Scholar

16. Hrabovszky Z, Farmer PJ, Hutson JM. Does the sensory nucleus of the genitofemoral nerve have a role in testicular descent? J Pediatr Surg 2000;35:96–100.10.1016/S0022-3468(00)80022-6Suche in Google Scholar

17. Ng SL, Bidarkar SS, Sourial M, Farmer PJ, Donath S, et al. Gubernacular cell division in different rodent models of cryptorchidism supports indirect androgenic action via the genitofemoral nerve. J Pediatr Surg 2005;40:434–41.10.1016/j.jpedsurg.2004.10.010Suche in Google Scholar PubMed

18. Hutson JM, Hasthorpe S. Testicular descent and cryptorchidism: the state of the art in 2004. J Pediatr Surg 2005;40:297–302.10.1016/j.jpedsurg.2004.10.033Suche in Google Scholar PubMed

19. Foresta C, Zuccarello D, Garolla A, Ferlin A. Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29:560–80.10.1210/er.2007-0042Suche in Google Scholar PubMed

20. Bartlett JE, Lee SM, Mishina Y, Behringer RR, Yang N, et al. Gubernacular development in Müllerian inhibiting substance receptor-deficient mice. BJU Int 2002;89:113–8.10.1046/j.1464-4096.2001.00783.xSuche in Google Scholar PubMed

21. Ferlin A, Garolla A, Rigon F, Rasi Caldogno L, Lenzi A, et al. Changes in serum insulin-like factor 3 during normal male puberty. J Clin Endocrinol Metab 2006;91:3426–31.10.1210/jc.2006-0821Suche in Google Scholar PubMed

22. Overbeek PA, Gorlov IP, Sutherland RW, Houston JB, Harrison WR, et al. A transgenic insertion causing cryptorchidism in mice. Genesis 2001;30:26–35.10.1002/gene.1029Suche in Google Scholar PubMed

23. Yamazawa K, Wada Y, Sasagawa I, Aoki K, Ueoka K, et al. Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Horm Res 2007;67:73–6.10.1159/000096089Suche in Google Scholar PubMed

24. Hutson JM, Nation T, Balic A, Southwell BR. The role of the gubernaculum in the descent and undescent of the testis. Ther Adv Urol 2009;1:115–21.10.1177/1756287209105266Suche in Google Scholar PubMed PubMed Central

25. Park K, Choi H. An evolution of orchiopexy: historical aspect. Korean J Urol 2010;51:155–60.10.4111/kju.2010.51.3.155Suche in Google Scholar PubMed PubMed Central

26. Barteczko KJ, Jacob MI. The testicular descent in human. Origin, development and fate of the gubernaculum Hunteri, processus vaginalis peritonei, and gonadal ligaments. Adv Anat Embryol Cell Biol 2000;156:III-X, 1–98.10.1007/978-3-642-58353-7_4Suche in Google Scholar

27. Virtanen HE, Cortes D, Rajpert-De Meyts E, Ritzén EM, Nordenskjöld A, et al. Development and descent of the testis in relation to cryptorchidism. Acta Paediatr 2007;96:622–7.10.1111/j.1651-2227.2007.00244.xSuche in Google Scholar PubMed

28. Wohlfahrt-Veje C, Main KM, Skakkebaek NE. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clin Endocrinol (Oxf) 2009;71:459–65.10.1111/j.1365-2265.2009.03545.xSuche in Google Scholar PubMed

29. Sharpe RM. The ‘oestrogen hypothesis’ – where do we stand now? Int J Androl 2003;26:2–15.10.1046/j.1365-2605.2003.00367.xSuche in Google Scholar PubMed

30. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972–8.10.1093/humrep/16.5.972Suche in Google Scholar PubMed

31. Sharpe RM, McKinnell C, Kivlin C, Fisher JS. Proliferation and functional maturation of sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003;125:769–84.10.1530/rep.0.1250769Suche in Google Scholar PubMed

32. Mylchreest E, Sar M, Wallace DG, Foster PM. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod Toxicol 2002;16:19–28.10.1016/S0890-6238(01)00201-5Suche in Google Scholar

33. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003;200:370–4.10.1002/path.1372Suche in Google Scholar PubMed

34. Guminska A, Oszukowska E, Kuzanski W, Sosnowski M, Wolski JK, et al. Less advanced testicular dysgenesis is associated by a higher prevalence of germ cell neoplasia. Int J Androl 2010;33:e153–62.10.1111/j.1365-2605.2009.00981.xSuche in Google Scholar PubMed

35. Mouriquand PD. Undescended testes in children: the paediatric urologist’s point of view. Eur J Endocrinol 2008;159(Suppl 1):S83–6.10.1530/EJE-08-0162Suche in Google Scholar PubMed

36. Ashley RA, Barthold JS, Kolon TF. Cryptorchidism: pathogenesis, diagnosis, treatment and prognosis. Urol Clin North Am 2010;37:183–93.10.1016/j.ucl.2010.03.002Suche in Google Scholar PubMed

37. Tasian GE, Copp HL, Baskin LS. Diagnostic imaging in cryptorchidism: utility, indications, and effectiveness. J Pediatr Surg 2011;46:2406–13.10.1016/j.jpedsurg.2011.08.008Suche in Google Scholar PubMed PubMed Central

38. Kanemoto K, Hayashi Y, Kojima Y, Maruyama T, Ito M, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of non-palpable testis. Int J Urol 2005;12:668–72.10.1111/j.1442-2042.2005.01102.xSuche in Google Scholar PubMed

39. Pirgon Ö, Dündar BN. Vanishing testes: a literature review. J Clin Res Pediatr Endocrinol 2012;4:116–20.10.4274/Jcrpe.728Suche in Google Scholar PubMed PubMed Central

40. Elderwy AA, Kurkar A, Abdel-Kader MS, Abolyosr A, Al-Hazmi H, et al. Laparoscopic versus open orchiopexy in the management of peeping testis: a multi-institutional prospective randomized study. J Pediatr Urol 2014;10:605–9.10.1016/j.jpurol.2014.06.006Suche in Google Scholar PubMed

41. Spires SE, Woolums CS, Pulito AR, Spires SM. Testicular regression syndrome: a clinical and pathologic study of 11 cases. Arch Pathol Lab Med 2000;124:694–8.10.5858/2000-124-0694-TRSSuche in Google Scholar PubMed

42. Bader MI, Peeraully R, Ba’ath M, McPartland J, Baillie C. The testicular regression syndrome – do remnants require routine excision? J Pediatr Surg 2011;46:384–6.10.1016/j.jpedsurg.2010.11.018Suche in Google Scholar

43. Keys C, Heloury Y. Retractile testes: a review of the current literature. J Pediatr Urol 2012;8:2–6.10.1016/j.jpurol.2011.03.016Suche in Google Scholar

44. Dhandore P, Hombalkar NN, Gurav PD, Ahmed MH. Vanishing testis syndrome: report of two cases. J Clin Diagn Res 2014;8:ND03-4.Suche in Google Scholar

45. Storm D, Redden T, Aguiar M, Wilkerson M, Jordan G, et al. Histologic evaluation of the testicular remnant associated with the vanishing testes syndrome: is surgical management necessary? Urology 2007;70:1204–6.10.1016/j.urology.2007.08.020Suche in Google Scholar

46. Wohlfahrt-Veje C, Boisen KA, Boas M, Damgaard IN, Kai CM, et al. Acquired cryptorchidism is frequent in infancy and childhood. Int J Androl 2009;32:423–8.10.1111/j.1365-2605.2008.00946.xSuche in Google Scholar

47. Hack WW, Sijstermans K, van Dijk J, van der Voort-Doedens LM, de Kok ME, et al. Prevalence of acquired undescended testis in 6-year, 9-year and 13-year-old Dutch schoolboys. Arch Dis Child 2007;92:17–20.10.1136/adc.2005.076208Suche in Google Scholar

48. Agarwal PK, Diaz M, Elder JS. Retractile testis – is it really a normal variant? J Urol 2006;175:1496–9.10.1016/S0022-5347(05)00674-9Suche in Google Scholar

49. Hutson JM. Journal of Pediatric Surgery-Sponsored Fred McLoed Lecture. Undescended testis: the underlying mechanisms and the effects on germ cells that cause infertility and cancer. J Pediatr Surg 2013;48:903–8.10.1016/j.jpedsurg.2013.02.001Suche in Google Scholar

50. Ong C, Hasthorpe S, Hutson JM. Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation. Pediatr Surg Int 2005;21:240–54.10.1007/s00383-005-1382-0Suche in Google Scholar

51. Rusnack SL, Wu HY, Huff DS, Snyder HM 3rd, Zderic SA, et al. The ascending testis and the testis undescended since birth share the same histopathology. J Urol 2002;168:2590–1.10.1016/S0022-5347(05)64223-1Suche in Google Scholar

52. Rusnack SL, Wu HY, Huff DS, Snyder HM 3rd, Carr MC, et al. Testis histopathology in boys with cryptorchidism correlates with future fertility potential. J Urol 2003;169:659–62.10.1016/S0022-5347(05)63986-9Suche in Google Scholar

53. Bae KH, Park JS, Jung HJ, Shin HS. Inguinal approach for the management of unilateral non-palpable testis: is diagnostic laparoscopy necessary? J Pediatr Urol 2014;10:233–6.10.1016/j.jpurol.2013.09.022Suche in Google Scholar

54. Cortesi N, Ferrari P, Zambarda E, Manenti A, Baldini A, et al. Diagnosis of bilateral abdominal cryptorchidism by laparoscopy. Endoscopy 1976;8:33–4.10.1055/s-0028-1098372Suche in Google Scholar

55. Mehendale VG, Shenoy SN, Shah RS, Chaudhari NC, Mehendale AV. Laparoscopic management of impalpable undescended testes: 20 years’ experience. J Minim Access Surg 2013;9:149–53.10.4103/0972-9941.118822Suche in Google Scholar

56. Park JH, Park YH, Park K, Choi H. Diagnostic laparoscopy for the management of impalpable testes. Korean J Urol 2011;52:355–8.10.4111/kju.2011.52.5.355Suche in Google Scholar

57. Vos A, Vries AM, Smets A, Verbeke J, Heij H, et al. The value of ultrasonography in boys with a non-palpable testis. J Pediatr Surg 2014;49:1153–5.10.1016/j.jpedsurg.2013.09.011Suche in Google Scholar

58. Hassan ME, Mustafawi A. Laparoscopic management of impalpable testis in children, new classification, lessons learned, and rare anomalies. J Laparoendosc Adv Surg Tech A 2010;20:265–9.10.1089/lap.2009.0244Suche in Google Scholar

59. Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, et al. Nordic consensus on treatment of undescended testes. Acta Paediatr 2007;96:638–43.10.1111/j.1651-2227.2006.00159.xSuche in Google Scholar

60. Esposito C, De Lucia A, Palmieri A, Centonze A, Damiano R, et al. Comparison of five different hormonal treatment protocols for children with cryptorchidism. Scand J Urol Nephrol 2003;37:246–9.10.1080/00365590310008136Suche in Google Scholar

61. Kaleva M, Toppari J. Cryptorchidism: an indicator of testicular dysgenesis? Cell Tissue Res 2005;322:167–72.10.1007/s00441-005-1143-3Suche in Google Scholar

62. Cortes D, Thorup J, Visfeldt J. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J Urol 2000;163:1290–2.10.1016/S0022-5347(05)67763-4Suche in Google Scholar

63. Hrivatakis G, Astfalk W, Schmidt A, Hartwig A, Kugler T, et al. The timing of surgery for undescended testis – a retrospective multicenter analysis. Dtsch Arztebl Int 2014;111:649–57.Suche in Google Scholar

64. Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician 2000;62: 2037–44, 2047–8.Suche in Google Scholar

65. Kass E, Kogan SJ, Manley C, Wacksman JA, Klykylo WM, et al. Timing of elective surgery on the genitalia of male children with particular reference to the risks, benefits, and psychological effects of surgery and anesthesia. American Academy of Pediatrics. Pediatrics 1996;97:590–4.Suche in Google Scholar

66. Chan E, Wayne C, Nasr A; FRCSC for Canadian Association of Pediatric Surgeon Evidence-Based Resource. Ideal timing of orchiopexy: a systematic review. Pediatr Surg Int 2014;30:87–97.10.1007/s00383-013-3429-ySuche in Google Scholar

67. Hadziselimovic F, Huff D. Gonadal differentiation – normal and abnormal testicular development. Adv Exp Med Biol 2002;511:15–21; discussion 21–3.10.1007/978-1-4615-0621-8_2Suche in Google Scholar

68. Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, et al. Abnormal germ cell development in cryptorchidism. Horm Res 2001;55:11–7.10.1159/000049957Suche in Google Scholar

69. Hadziselimovic F, Zivkovic D, Bica DT, Emmons LR. The importance of mini-puberty for fertility in cryptorchidism. J Urol 2005;174(4 Pt 2):1536–9; discussion 1538–9.10.1097/01.ju.0000181506.97839.b0Suche in Google Scholar

70. Hadziselimovic F, Herzog B. The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 2001;358:1156–7.10.1016/S0140-6736(01)06274-2Suche in Google Scholar

71. Chung E, Brock GB. Cryptorchidism and its impact on male fertility: a state of art review of current literature. Can Urol Assoc J 2011;5:210–4.10.5489/cuaj.1010Suche in Google Scholar

72. Trsinar B, Muravec UR. Fertility potential after unilateral and bilateral orchidopexy for cryptorchidism. World J Urol 2009;27:513–9.10.1007/s00345-009-0406-0Suche in Google Scholar

73. Hutson JM, Li R, Southwell BR, Petersen BL, Thorup J, et al. Germ cell development in the postnatal testis: the key to prevent malignancy in cryptorchidism? Front Endocrinol (Lausanne) 2012;3:176.10.3389/fendo.2012.00176Suche in Google Scholar

74. Engeler DS, Hösli PO, John H, Bannwart F, Sulser T, et al. Early orchiopexy: prepubertal intratubular germ cell neoplasia and fertility outcome. Urology 2000;56:144–8.10.1016/S0090-4295(00)00560-4Suche in Google Scholar

75. Hutson JM, Balic A, Nation T, Southwell B. Cryptorchidism. Semin Pediatr Surg 2010;19:215–24.10.1053/j.sempedsurg.2010.04.001Suche in Google Scholar PubMed

76. Lee PA. Fertility after cryptorchidism: epidemiology and other outcome studies. Urology 2005;66:427–31.10.1016/j.urology.2005.01.017Suche in Google Scholar PubMed

77. Walsh TJ, Dall’Era MA, Croughan MS, Carroll PR, Turek PJ. Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 2007;178(4 Pt 1):1440–6; discussion 1446.10.1016/j.juro.2007.05.166Suche in Google Scholar PubMed

78. Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, et al. What is new in cryptorchidism and hypospadias – a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg 2010;45:2074–86.10.1016/j.jpedsurg.2010.07.030Suche in Google Scholar PubMed

79. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2–14.10.1007/s00345-004-0398-8Suche in Google Scholar PubMed

80. Ferguson L, Agoulnik AI. Testicular cancer and cryptorchidism. Front Endocrinol (Lausanne) 2013;4:32.10.3389/fendo.2013.00032Suche in Google Scholar PubMed PubMed Central

81. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 2007;356:1835–41.10.1056/NEJMoa067588Suche in Google Scholar PubMed

82. Bruijnen CJ, Vogels HD, Beasley SW. Age at orchidopexy as an indicator of the quality of regional child health services. J Paediatr Child Health 2012;48:556–9.10.1111/j.1440-1754.2011.02202.xSuche in Google Scholar PubMed

Received: 2015-2-25
Accepted: 2015-6-8
Published Online: 2015-7-30
Published in Print: 2015-11-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Turner syndrome
  3. Turner syndrome – working together with patients and their families
  4. Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)
  5. Inhibin B in adolescents and young adults with Turner syndrome
  6. Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experience
  7. Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen
  8. Turner syndrome in Albania and the efficacy of its treatment with growth hormone
  9. Review articles
  10. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update
  11. Putting the pieces together: cryptorchidism – do we know everything?
  12. Original articles
  13. Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development
  14. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing
  15. Association of physical activity level with depression, anxiety, and quality of life in children with type 1 diabetes mellitus
  16. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment
  17. The effect of intraoperative administration of dexamethasone for PONV prophylaxis on perioperative blood glucose level in obese and normal weight children
  18. Are obesity and metabolic syndrome associated with plasma adropin levels in children?
  19. Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
  20. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity
  21. Effect of serum cholesterol on bone mineral density in normal-weight children and adolescents
  22. Assessment of bone turnover markers and bone mineral density in normal short boys
  23. Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?
  24. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets
  25. Children with hyperthyroidism younger than age 7 require higher mg/kg doses of methimazole to normalize free T4 compared to older children
  26. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis
  27. AMH levels at central precocious puberty and premature thelarche: is it a parameter?
  28. Validating Paediatric Morphometrics: body proportion measurement using photogrammetric anthropometry
  29. Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome
  30. Short communication
  31. Pilot study on the dietary habits and lifestyles of girls with idiopathic precocious puberty from the city of Rome: potential impact of exposure to flame retardant polybrominated diphenyl ethers
  32. Patient reports
  33. Hypomagnesemia due to two novel TRPM6 mutations
  34. A novel mutation of AMH in three siblings with persistent Mullerian duct syndrome
  35. Kocher-Debré-Semelaigne syndrome with rhabdomyolysis and increased creatinine
  36. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty
  37. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0098/pdf
Button zum nach oben scrollen